Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 01, 2015 8:29 PM ET

Pharmaceuticals

Company Overview of Shasun Pharmaceuticals Ltd

Company Overview

Shasun Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and formulations to the pharmaceutical industry primarily in India. The company offers API products in the areas of pain management and musculoskeletal, central nervous system, cardiovascular, hyperphosphataemia, COPD, anti-infective, gastrointestinal, gastrointestinal, cough suppressants, and anti-emetic. It also engages in the contract research and manufacturing services business, which provides chemistry and analytical services; and offers formulation development and manufacturing services for solid dosage products to pharmaceutical customers. In addition, it offers enteric coati...

Batra Centre

3rd & 4th Floor

28, Sardar Patel Road

Guindy

Chennai,  600032

India

Founded in 1976

Phone:

91 44 4344 6700

Fax:

91 44 2235 0278

Key Executives for Shasun Pharmaceuticals Ltd

Chief Executive Officer, Managing Director, Wholetime Director, Member of Stakeholders Relationship Committee and Member of Risk Management Committee
Age: 62
Total Annual Compensation: $13.0M
Chief Financial Officer
Total Annual Compensation: $8.6M
Director of Operations & EHS and Whole Time Director
Age: 53
Total Annual Compensation: $3.6M
Wholetime Director
Age: 59
Total Annual Compensation: $8.6M
Whole-Time Director and Member of Corporate Social Responsibility Committee
Age: 64
Total Annual Compensation: $8.6M
Compensation as of Fiscal Year 2015.

Shasun Pharmaceuticals Ltd Key Developments

Shasun Pharmaceuticals Ltd Declares Interim Dividend

Shasun Pharmaceuticals Ltd. announced that the board of directors of the company at its meeting held on July 30, 2015, has approved the interim dividend of 50% (INR 1 per share) on the equity shares of face value of INR 2 each.

Shasun Pharmaceuticals Ltd. Announces Unaudited Standalone and Consolidated Earnings Results for the First Quarter Ended June 30, 2015

Shasun Pharmaceuticals Ltd. announced unaudited standalone and consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, the standalone company reported net sales of INR 2,455.5 million against INR 2,369.8 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 161.5 million against INR 113.7 million a year ago. Profit from ordinary activities before tax was INR 77.2 million against INR 36.6 million a year ago. Net profit was INR 69.9 million against INR 36.6 million a year ago. Diluted earnings per share before and after extraordinary items were INR 1.10 against INR 0.63 a year ago. For the quarter, the consolidated company reported net sales of INR 3,191.7 million against INR 2,997.7 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 162.6 million against INR 46.6 million a year ago. Profit from ordinary activities before tax was INR 49.9 million against loss of INR 50.1 million a year ago. Net profit was INR 38.0 million against loss of INR 47.9 million a year ago. Diluted earnings per share before and after extraordinary items were INR 0.60 against loss of INR 0.83 a year ago. EBITDA of INR 383 million against INR 208 million a year ago.

Shasun Pharmaceuticals Ltd to Report Q1, 2016 Results on Jul 30, 2015

Shasun Pharmaceuticals Ltd announced that they will report Q1, 2016 results on Jul 30, 2015

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
February 7, 2015
Alivira Animal Health Limited
Merger/Acquisition
December 31, 2014
--
Merger/Acquisition
September 29, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Shasun Pharmaceuticals Ltd, please visit www.shasun.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.